Navigation Links
Rigel Announces First Quarter 2009 Financial Results
Date:5/5/2009

SOUTH SAN FRANCISCO, Calif., May 5 /PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today reported financial results for the first quarter ended March 31, 2009.

For the first quarter of 2009, Rigel reported a net loss of $29.9 million, or $0.82 per share, compared to a net loss of $27.3 million, or $0.79 per share, in the first quarter of 2008. Weighted average shares outstanding for the first quarters of 2009 and 2008 were 36.7 million and 34.4 million, respectively.

Rigel reported total operating expenses of $30.3 million in the first quarter of 2009, compared to $28.7 million in the first quarter of 2008. The increase in operating expenses was primarily due to increases in clinical development and restructuring costs, partially offset by the decrease in stock-based compensation expense. The increase in clinical development expenses was primarily due to the costs associated with the Company's two Phase 2b clinical trials of R788 in rheumatoid arthritis (TASKi2 and TASKi3). As a result of the restructuring implemented in the first quarter of 2009, Rigel recorded restructuring charges of $1.1 million which consisted primarily of severance payments and extended health benefits for the affected employees. Stock-based compensation expenses decreased from $5.8 million in the first quarter of 2008 to $2.3 million in the first quarter of 2009, primarily due to the higher valuation of options granted in the first quarter of 2008 and the full expense recognition of the majority of those options by the end of 2008.

In the first quarter of 2009, Rigel recorded a federal refundable tax benefit of approximately $66,000, which was calculated in accordance with The American Recovery and Reinvestment Act of 2009.

As of March 31, 2009, Rigel had cash, cash equivalents and available for
'/>"/>

SOURCE Rigel Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Rigel to Present at BIO Investor Forum 2007
2. Rigel to Present Research Programs at Scientific Conferences
3. Rigel Announces Pricing of Public Offering of Common Stock
4. Rigel to Present at BIO CEO & Investor Conference
5. Rigel Announces Fourth Quarter and Year End 2007 Financial Results
6. Rigel to Host Update Conference Call
7. Rigel Announces Third Quarter 2008 Financial Results and Clinical Update
8. Rigel to Present at the 2008 Credit Suisse Healthcare Conference
9. Rigel to Host Conference Call to Discuss Phase 2 Study Results of R788 in Lymphoma Presented at ASH
10. Rigel to Participate at the RBC Capital Markets Healthcare Conference
11. Rigel to Present at Citis Biotech Day
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/12/2010)... testing, is taking strides to expand their Product and Material Testing ... ... Minneapolis, MN (PRWEB) March 12, 2010 -- DDL , ... strides to expand their Product and Material Testing Division by promoting ... helping medical device manufacturers get to market for almost 20 years. ...
(Date:3/11/2010)... Calif. , March 11 Bone Biologics, Inc. announced today that it has received a US Patent Office Notice of Allowance of patent ... protein by several delivery agents. , ... , , ... ... ...
(Date:3/11/2010)... Best Practices Will Be Discussed and Demonstrated at Philadelphia Conference ... ... 11, 2010 -- ClearTrial, the leading provider of Clinical Trial ... discussion which includes pharmaceutical analysts from Deutsche Bank and Cowen ... Philadelphia, Pennsylvania, March 16-17. This conference is attended each year ...
(Date:3/10/2010)... Thomson Reuters today announced it has launched the highly ... Education,s influential World University Rankings. The survey reflects a new approach ... global scholarly community. , ... ... ...
Breaking Biology Technology:DDL Expands the Product & Material Testing Division 2DDL Expands the Product & Material Testing Division 3Bone Biologics Announces a Major US Patent Issuance For Its Recombinant Protein Process For the Formation of Cartilage 2Bone Biologics Announces a Major US Patent Issuance For Its Recombinant Protein Process For the Formation of Cartilage 3ClearTrial to Head Panel of Leading Wall Street Analysts at Pharmaceutical Accounting and Reporting Congress 2ClearTrial to Head Panel of Leading Wall Street Analysts at Pharmaceutical Accounting and Reporting Congress 3Thomson Reuters Launches Academic Reputation Survey as Part of Global Institutional Profiles Project 2Thomson Reuters Launches Academic Reputation Survey as Part of Global Institutional Profiles Project 3
... FOREST, Ill., Oct. 7 Hospira, Inc.,(NYSE: HSP ... today announced that it will host a conference call ... 2008, at 8,a.m. Central time., The company will ... stock market open and the conference call., A ...
... Morria Biopharmaceuticals Plc, a,biopharmaceutical company ... drugs, announced today the results of ... drugs using MD Biosciences,Immunoprofiler(TM) in vitro ... to identify and assess the anti-inflammatory ...
... - PathHunter eXpress Kits Combined with LabChip Microfluidic ... GPCR Assay Solution -, HOPKINTON, Mass. and ... (Nasdaq: CALP ) and DiscoveRx, today announced,the ... with Caliper,s LabChip(R) 3000 and EZ Reader(TM) platforms ...
Other Biology Technology:Morria Biopharmaceuticals Plc Announces Results From its Pre-Clinical Screening of Novel Anti-Inflammatory Compounds 2Caliper Life Sciences and DiscoveRx Announce Availability of PathHunter eXpress Reagents for GPCR Assays 2Caliper Life Sciences and DiscoveRx Announce Availability of PathHunter eXpress Reagents for GPCR Assays 3
(Date:3/11/2010)... A 2010 American Society for Microbiology (ASM) Raymond W. ... an undergraduate student at Juniata College, Huntington, PA, for ... presented in honor of the late Raymond W. ... of the ASM. , Johnson has spent the ... Streptomyces coelicolor . He examined transposon insertion mutants with ...
(Date:3/11/2010)... and dust about 1,900 feet in diameter that could tell ... light on how life began. It also might hit us ... the birth of our solar system," said Bill Cutlip of ... the leaders of Goddard,s effort to propose a mission called ... If selected, Goddard will provide overall mission management for OSIRIS-REx, ...
(Date:3/11/2010)... of people in both the developing and developed ... from the University of Pennsylvania School of Veterinary ... the immune system operates, have discovered a previously ... double-edged sword, fighting off parasitic infections but also ... to allergies and asthma. , This cell population, ...
Breaking Biology News(10 mins):Proposed mission would return sample from asteroid 'time capsule' 2Proposed mission would return sample from asteroid 'time capsule' 3Proposed mission would return sample from asteroid 'time capsule' 4Proposed mission would return sample from asteroid 'time capsule' 5Penn researchers identify immune cells that fight parasites may promote allergies and asthma 2105th APSA Meeting worlds largest for the study of politics will be in Toronto Sept 3 6 55520 1105th APSA Meeting worlds largest for the study of politics will be in Toronto Sept 3 6 55520 2Curtain twitching skylarks keep track of strangers through their songs 9716 1Curtain twitching skylarks keep track of strangers through their songs 9716 2ESA helps make summer in the city more bearable 9714 1ESA helps make summer in the city more bearable 9714 2ESA helps make summer in the city more bearable 9714 3ESA helps make summer in the city more bearable 9714 4
... are characterized by extensive segments that are inactive, ... are closed to gene transcription. Scientists believe one ... vital need for genomic stability, for protection against ... of the genome's integrity. , Genomic instability, particularly ...
... the flow of water molecules through the brain can help ... if a patient's tumor will shrink, a new study shows. ... developed the assessment, which they call a functional diffusion map. ... diffusion, or movement, of water through the brain and mapped ...
... of biomedical science and the development of high-throughput ... information from biomedical text has become critical. Since ... for interpreting large amounts of high-throughput data efficiently, ... to gene functions from text has been increasing. ...
Other Biology News:Enzyme shown to help protect genomic stability 2New imaging method gives early indication if brain cancer therapy is effective, U-M study shows 2New imaging method gives early indication if brain cancer therapy is effective, U-M study shows 3
Rabbit anti Xanthine Oxidase Xanthine Oxidase, Bovine Buttermilk...
... This CLS number is ... created to easily match ... showing no availability yet, ... old Sigma-Aldrich number (Z71,448-8) ...
This CLS number is a new product number, created to easily match Cornings product number. If showing no availability yet, please order under the old Sigma-Aldrich number (E6027) or contact customer s...
... This high pressure gradient system ... piston pumps, each providing a flow rate in ... dual wavelength detector for added flexibility. System ... data processing software and interface unit, CE 4900., ...
Biology Products: